Educational - Neurochase

NEUROCHASE ANNOUNCES ACQUISITION OF STRATEGIC RENISHAW NEURO SOLUTIONS’ ASSETS

DuncanarioNCH November 20, 2025 No Comments

CREATING A PREMIER GLOBAL PLATFORM FOR TARGETED CNS DRUG DELIVERY – Sale agreement for Renishaw Neuro Solutions’ Neuroinfuse™ drug delivery system a key milestone as Neurochase prepares to use this pioneering CNS [...]

Neurochase to exhibit and present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting next month

Peter Carroll April 23, 2025 No Comments

We can confirm today (Wednesday, April 23, 2025) that Neurochase will be a first-time exhibitor at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting next month. [...]

Spark Therapeutics Enters Into Strategic Collaboration with Neurochase

DuncanarioNCH January 18, 2024 No Comments

Original Article: Global News Wire Spark Therapeutics Enters Into Strategic Collaboration with Neurochase for Use of Proprietary Delivery Technology for CNS Disorders PHILADELPHIA, Jan. 27, 2023 (GLOBE NEWSWIRE) — Spark [...]

Novel Gene Therapy for Motor Neurone Disease (MND) & Parkinson’s (PD)

DuncanarioNCH January 18, 2024 No Comments

Innervate Therapeutics is a biotechnology company focused on developing glial cell -derived neurotrophic factor (GDNF) gene therapies to achieve neuro-restoration and neuroprotection in diseases including PD and MND. GDNF, a [...]

Category: Educational

NEUROCHASE ANNOUNCES ACQUISITION OF STRATEGIC RENISHAW NEURO SOLUTIONS’ ASSETS

Neurochase to exhibit and present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting next month

Spark Therapeutics Enters Into Strategic Collaboration with Neurochase

Novel Gene Therapy for Motor Neurone Disease (MND) & Parkinson’s (PD)